Suppr超能文献

重组腺相关病毒包装能力的定量分析

Quantitative analysis of the packaging capacity of recombinant adeno-associated virus.

作者信息

Dong J Y, Fan P D, Frizzell R A

机构信息

Department of Laboratory Medicine, University of California, San Francisco, 94143-0724, USA.

出版信息

Hum Gene Ther. 1996 Nov 10;7(17):2101-12. doi: 10.1089/hum.1996.7.17-2101.

Abstract

Recombinant adeno-associated viruses (AAV) are among the most promising vectors for gene therapy of genetic diseases, including cystic fibrosis (CF). However, because of its small genome size, the capacity of AAV to package a therapeutic gene is limited. The efficiency of packaging the cystic fibrosis transmembrane conductance Regulator (CFTR) gene into AAV will be an important factor in determining whether recombinant AAV can be developed as a vector for transferring CFTR cDNA to the airway epithelia of patients with CF. Current understanding of the AAV biology suggests that AAV can package a genome slightly larger than the size of a wild-type genome. The precise range of the genome size and the efficiency of packaging have not been defined. Using a series of AAV vectors with progressively-increasing genome size, we were able to analyze quantitatively the packaging efficiency in relation to the vector size and to determine the size limit for packaging. The packaging efficiencies of AAV vectors of variable sizes were determined directly by assaying DNA contents of viral particles, and indirectly by analyzing their efficiency in transfer of a chloramphenicol acetyltransferase (CAT) reporter gene into target cells. Our studies showed that the optimal size of AAV vector is between 4.1 and 4.9 kb. Although AAV can package a vector larger than its genome size, up to 5.2 kb, the packaging efficiencies in this large size range were sharply reduced. When the AAV genome size was smaller than 4.1 kb, the packaging efficiency was also suboptimal. In contrast, when the size of the genome was less than half the length of the wild-type genome, two copies of the vector were packaged into each virion, suggesting that the copy number control during packaging is a "head-full" mechanism. Because the length of the minimal cDNA of CFTR is about 4.5 kb, these results suggest it is possible to package the CFTR gene into AAV if the combined length of transcriptional elements and ITRs is kept under 500 bp. The results of this study are important for directing the design of AAV vectors for efficient gene transfer, as well as for a better understanding of the mechanism of AAV genome packaging.

摘要

重组腺相关病毒(AAV)是用于包括囊性纤维化(CF)在内的遗传病基因治疗的最有前景的载体之一。然而,由于其基因组规模小,AAV包装治疗性基因的能力有限。将囊性纤维化跨膜传导调节因子(CFTR)基因包装到AAV中的效率将是决定重组AAV是否能够开发成为将CFTR cDNA转移至CF患者气道上皮细胞的载体的一个重要因素。目前对AAV生物学的认识表明,AAV能够包装一个略大于野生型基因组规模的基因组。基因组规模的精确范围以及包装效率尚未明确。使用一系列基因组规模逐渐增加的AAV载体,我们能够定量分析与载体规模相关的包装效率,并确定包装的规模限制。通过测定病毒颗粒的DNA含量直接确定不同规模AAV载体的包装效率,并通过分析它们将氯霉素乙酰转移酶(CAT)报告基因转移至靶细胞的效率间接确定包装效率。我们的研究表明,AAV载体的最佳规模在4.1至4.9 kb之间。尽管AAV能够包装一个大于其基因组规模的载体,最大可达5.2 kb,但在这个大的规模范围内包装效率急剧降低。当AAV基因组规模小于4.1 kb时,包装效率也不理想。相反,当基因组规模小于野生型基因组长度的一半时,每个病毒粒子会包装两份载体,这表明包装过程中的拷贝数控制是一种“满头部”机制。由于CFTR最小cDNA的长度约为4.5 kb,这些结果表明,如果转录元件和ITR的总长度保持在500 bp以下,就有可能将CFTR基因包装到AAV中。本研究结果对于指导高效基因转移的AAV载体设计以及更好地理解AAV基因组包装机制具有重要意义。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验